906672-79-5

Basic information

• Product Name: methyl 4-((2-methoxyethoxy)methoxy)benzoate
• Synonyms: methyl 4-((2-methoxyethoxy)methoxy)benzoate
• CAS NO: 906672-79-5
• Molecular Weight: 240.256
• Mol File: 906672-79-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 4-((2-methoxyethoxy)methoxy)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-((2-methoxyethoxy)methoxy)benzoate(906672-79-5)
• EPA Substance Registry System: methyl 4-((2-methoxyethoxy)methoxy)benzoate(906672-79-5)

Safety Data

• Hazardous Substances Data: 906672-79-5(Hazardous Substances Data)

Upstream product

• 110-71-4 1,2-dimethoxyethane 
• 99-76-3 methyl 4-hydroxylbenzoate 
• 3970-21-6 2-Methoxyethoxymethyl chloride 

Downstream Products

• 1271521-46-0 (S)-2-(4-methanesulphonylpiperazin-1-yl)-3-(4-methoxybenzoylamino)propanoic acid 
• 1271521-45-9 methyl (S)-2-(4-methanesulphonylpiperazin-1-yl)-3-(4-methoxybenzoylamino)propanoate 
• 1271521-44-8 methyl (S)-3-(4-hydroxybenzoylamino)-2-(4-methanesulphonylpiperazin-1-yl)propanoate 
• 1271521-43-7 methyl (S)-2-(4-methanesulphonylpiperazin-1-yl)-3-[4-(2-methoxyethoxymethoxy)benzoylamino]propanoate 
• 1271521-78-8 methyl (S)-2-(4-methanesulphonylpiperazin-1-yl)-3-[4-(pyridin-4-ylmethoxy)benzoylamino]propanoate 
• 906672-80-8 (S)-4-isopropyl-2-[4-(methoxyethoxymethoxy)phenyl]oxazoline 

Relevant articles and documents

Construction of C–O bond via cross-dehydrogenative coupling of sp [ 3] C–H bond with phenols catalyzed by copper porphyrin

Copper porphyrin-catalyzed construction of ether bond by cross-dehydrogenative coupling of sp [3] C–H bond with phenols bearing electron-withdrawing groups (EWG) was described for the first time. A broad range of substrates afforded different acetals in m

N- [2-HYDROXYCARBAMOYL-2- (PIPERAZINYL) ETHYL] BENZAMIDE COMPOUNDS, THEIR PREPARATION AND THEIR USE AS TACE INHIBITORS

The present invention relates to novel benzene-carboxamide compounds having a structure that corresponds to the general formula (I), and also to their method of synthesis and to their use in pharmaceutical compositions intended for use in human or veterinary medicine or else to their use in cosmetic compositions.